Featured Research

from universities, journals, and other organizations

Protection of the heart at a distance

Date:
January 13, 2012
Source:
Universität Duisburg-Essen
Summary:
Novel avenues to treat a heart attack have been developed: in patients, who have a blood pressure cuff several times briefly inflated before they undergo coronary artery surgery with cardiopulmonary bypass, the heart is protected from damage.

Novel avenues to treat a heart attack have been developed: in patients, who have a blood pressure cuff several times briefly inflated before they undergo coronary artery surgery with cardiopulmonary bypass, the heart is protected from damage.

This is the result of a clinical study recently reported by a group of scientists from the University Duisburg-Essen (UDE) in Circulation Research, the official journal of the American Heart Association.

A team of researchers from the Institute of Pathophysiology, the Clinic of Cardiothoracic Surgery and the Clinic of Anesthesiology, which was led by Professor Gerd Heusch, found such protection of the heart at a distance. They first identified STAT5 as a protective molecular signal in the human heart. STAT signals improve the function of mitochondria, i.e. the cellular powerplants, and reduce the size of a myocardial infarction in the experiment.

In a myocardial infarction, parts of the cardiac muscle receive no blood supply because the coronary vessels are occluded. Cardiovascular disease is the most frequent cause of death in Germany, and 70.000 people annually die from myocardial infarction in Germany. The basic and translational research of Prof. Heusch on protection of the heart from infarction is supported by the German Research Foundation.


Story Source:

The above story is based on materials provided by Universität Duisburg-Essen. Note: Materials may be edited for content and length.


Journal Reference:

  1. Gerd Heusch, Judith Musiolik, Eva Kottenberg, Jürgen Peters, Heinz Jakob, Matthias Thielmann. STAT5 Activation and Cardioprotection by Remote Ischemic Preconditioning in Humans. Circulation Research, November 23, 2011 DOI: 10.1161/%u200BCIRCRESAHA.111.259556

Cite This Page:

Universität Duisburg-Essen. "Protection of the heart at a distance." ScienceDaily. ScienceDaily, 13 January 2012. <www.sciencedaily.com/releases/2012/01/120113210355.htm>.
Universität Duisburg-Essen. (2012, January 13). Protection of the heart at a distance. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2012/01/120113210355.htm
Universität Duisburg-Essen. "Protection of the heart at a distance." ScienceDaily. www.sciencedaily.com/releases/2012/01/120113210355.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) — The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) — The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) — The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) — In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins